Grimes & Company’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$59.2K Hold
2024
Q2
$39.3K Buy
2024
Q1
$303K Sell
2023
Q4
$373K Sell
2023
Q3
$281K Buy
2023
Q2
$377K Hold
2023
Q1
$240K Buy
2022
Q4
$138K Hold
2022
Q3
$230K Buy
2022
Q2
$164K Buy
2022
Q1
$306K Buy
2021
Q4
$305K Sell
2021
Q3
$331K Buy
2021
Q2
$474K Buy
2021
Q1
$369K Buy
2020
Q4
$149K Buy
2020
Q3
$145K Buy
2020
Q2
$42K Buy